All lobbying filings

MILLER STRATEGIES, LLC

MILLER STRATEGIES, LLC filed a Q1 report for AMGEN, INC. on April 20, 2026, reporting $60,000 in lobbying income.

Lobbying for AMGEN, INC. · biopharmaceutical company

All filings by MILLER STRATEGIES, LLC · Everything AMGEN, INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbying activity 3

Health Issues

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

Medicare/Medicaid

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Immigration

Issues related to visas

Bills named in this filing 1

H.R. 3517
Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.